Changes to Sanofi’s top tier

pharmafield logo - pharma news

Sanofi has announced a number of changes to its Executive Committee.

Chief Executive Officer and committee chair Olivier Brandicourt announced the changes in support of the company’s recently announced 2020 Strategic Roadmap.

As of June 1, 2016, Sanofi’s Executive Committee will consist of the following members:


  • Olivier Charmeil, Executive Vice President and General Manager, General Medicines and Emerging Markets*
  • Jérôme Contamine, Executive Vice President, Finance
  • Peter Guenter, Executive Vice President and General Manager, Diabetes & Cardiovascular*
  • Carsten Hellmann, Executive Vice President and General Manager of Merial
  • Karen Linehan, Executive Vice President, Legal Affairs and General Counsel
  • David Loew, Executive Vice President and General Manager of Sanofi Pasteur
  • Philippe Luscan, Executive Vice President, Global Industrial Affairs
  • Muzammil Mansuri, Ph.D., Executive Vice President, Strategy & Business Development
  • David Meeker, MD, Executive Vice President and General Manager of Sanofi Genzyme
  • Ameet Nathwani, MD, Executive Vice President, Medical Affairs (pictured)
  • Roberto Pucci, Executive Vice President, Human Resources
  • Elias Zerhouni, MD, President, Global Research & Development.


In other personnel changes in the company, Pascale Witz, Executive Vice President, Diabetes & Cardiovascular, will leave Sanofi on June 1. Since joining the company in July 2013, Pascale has been instrumental in signing strategic collaborations, including those with Verily Life Sciences (a subsidiary of Google) and Hanmi Pharmaceuticals.

Carsten Hellmann, Executive Vice President, Merial, has accepted a position as President and CEO of ALK but will stay with Sanofi until the end of the year to support the strategic business swap project with Boehringer Ingelheim.

Suresh Kumar, Executive Vice President, External Affairs, will return to the United States where he will continue to represent Sanofi’s interest in the country until the year-end. Olivier Brandicourt will serve as acting head of External Affairs until a replacement is found to succeed Suresh.

*Denotes change in position for existing Executive Committee member.